The Global Health Body Raises Warning Over Acute Lack of Weight-Loss Medications

Fewer than 10% of people that would benefit from obesity jabs such as Wegovy have access to them, warns the global health agency as it issues its initial recommendations on the medications.

Considering more than one billion individuals worldwide now classified as obese, it is advocating for increased and just availability to this class of drugs.

Based on projections, more than two billion could be obese by 2030 if no action is taken.

"The latest guidelines affirms that obesity is a chronic disease that can be managed with comprehensive and continuous care," stated its chief Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and logistical bottlenecks are significant hurdles to universal access to the injections that can aid individuals in losing significant body mass, explains the body.

Weight-Loss Drug Shortage

Despite the current best projected outlook, the manufacturing of such drugs could only cover around 100 million people – under 10% of the global need, according to the health organization.

The guideline urges governments and firms to increase availability, via measures such as voluntary licensing.

Exclusive production rights on a key compound – the main ingredient of the drug Wegovy – is due to expire in a number of countries in 2026.

The Way Weight-Loss Jabs Operate

These medications replicate a natural hormone to delay gastric emptying, curb appetite and enhance feelings of fullness so individuals reduce food intake.

People commonly start to lose weight after several weeks of commencing the once-weekly jabs.

Studies suggests people may put most of the weight back on a year later of halting the treatment, as their usual hunger resume.

To be overweight or obese elevates your likelihood for developing medical conditions, including type 2 diabetes, cardiovascular issues, brain attack, and some malignancies.

Obesity affects people in countries worldwide and was responsible for 3.7 million fatalities worldwide in 2024, as per the WHO.